Industry news tidbits from around the world.
• In an attempt to stifle the spread of counterfeit drugs, Kenya has called upon intelligence units to catch counterfeiters through means similar to drug trafficking methods. Medical Services Minister Peter Anyang Nyongo said in a statement that his department plans to work with the National Security and Intelligence Services to improve surveillance methods and reduce the number of counterfeit drugs in Kenya, which, according to the country's National Quality Control Laboratories and the Pharmacy Poisons Board, make up about 30% of all drugs circulated throughout Kenya. Similarly, Rwanda is also looking at pharmacies across the country in an effort to determine the prevalence of counterfeit malaria drugs.
• A new World Trade Organization amendment may allow pharmaceutical companies to produce lower-cost generic antiretrovirals, malaria treatments, and other medicines for developing countries. Taiwan recently approved the first reading of the proposed amendment, which would facilitate the importation of cheaper, generic drugs to developing countries if they cannot manufacture the drugs themselves. Countries that have already approved the amendment are Australia, China, the European Union, Japan, South Korea, and the United States.
• Scientists in Germany and Russia are working in conjunction with researchers at the University of KwaZulu-Natal (Durban, South Africa) to create a database that could help shorten the diagnostic times of drug-resistant tuberculosis to a mere 48 hours.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.